People deserve
better answers.

genetics-icon
Genetic Testing Solutions

Innovative testing solutions for inherited genetic disorders, from fragile X syndrome to CFTR to SMN1/2.

AmplideX Genetics assay kits for Inherited Disorders
oncology-icon
Precision Oncology Solutions

Solving complex molecular challenges, from chronic myeloid leukemia (CML) to solid tumors.

Learn about our Precision Oncology Solutions & CML Monitoring
cdx-icon
Molecular Quality Controls

Custom & Ready-to-Order Molecular Quality Controls & OEM Services

Learn about our molecular quality controls
Spotlight

Dr. Jordan Laser Awarded AMP Meritorious Service Award

Bio-Techne and Asuragen are proud to share that Dr. Jordan Laser received the AMP Meritorious Service Award this year to recognize his work behind the scenes to position AMP as the premier molecular diagnostics professional association around the world. Dr. Laser serves as Senior Director, Clinical and Medical Affairs, for Bio-Techne's Diagnostics and Genomics Segment.

See the full Press Release
Spotlight

Join Asuragen at the Association for Molecular Pathology Annual Meeting 2023

Enjoy several Corporate Workshops to learn how our comprehensive suites of assays and services can empower you to provide better answers. Stop by our booth #1311 on Thursday & Friday during Exhibit hours to get Free Professional Headshots!

Join Asuragen at AMP 2023
Spotlight

Analyze Three Common Genetic Targets in a Single Workflow – AmplideX TRIO

The AmplideX® TRIO Workflow brings simplicity and scalability to FMR1, SMN1/2, and CFTR analysis and is optimized for use on widely established laboratory equipment. Easy to use Reporter Software included!

Streamline your Workflow Today
Spotlight

Asuragen Expands Genetic Portfolio with Launch of AmplideX® PCR/CE HTT Kit

The AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).

Read more about our HTT kit

The Latest from Asuragen

Simple, Sensitive, and Scalable: QuantideX® Suite of Assays for Targeted MRD Monitoring of Leukemic Fusions

View Asuragen’s Corporate Workshop from the AMP 2023 meeting to learn more about our QuantideX suite of assays.

Request To See Full Video

Back To
Top